Please login to the form below

Not currently logged in
Email:
Password:

everolimus

This page shows the latest everolimus news and features for those working in and with pharma, biotech and healthcare.

Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader

Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader

Pfizer and Arvinas are also planning to initiate two additional trials of ARV-471 this year, including a second phase 1b combination trial with cancer growth blocker everolimus, as well as

Latest news

More from news
Approximately 8 fully matching, plus 68 partially matching documents found.

Latest from PMHub

  • Oncology drugs under AMNOG

    patients the comparator was a different targeted therapy, Afinitor (everolimus), rather than Nexavar - although for cytokine-pretreated patients the trial comparator could be used.The G-BA still exercises its right

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...